What is the diagnosis for a patient with a 25‑hydroxy‑vitamin D level of 26 ng/mL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Vitamin D Insufficiency

A 25-hydroxyvitamin D level of 26 ng/mL indicates vitamin D insufficiency.

Diagnostic Classification

Based on the most authoritative guideline evidence, this level falls into the "insufficient" category:

  • Vitamin D deficiency: <20 ng/mL 1
  • Vitamin D insufficiency: 20-29 ng/mL 1
  • Vitamin D sufficiency: ≥30 ng/mL 1

The 2011 Endocrine Society Clinical Practice Guideline 1 established these thresholds based on PTH normalization studies and calcium absorption data. At 26 ng/mL, this patient has suboptimal vitamin D stores that warrant correction.

Clinical Significance

This level of 26 ng/mL has important implications:

  • PTH elevation risk: Multiple studies demonstrate that PTH levels begin to plateau only when 25(OH)D reaches 30-40 ng/mL 1. Below this threshold, secondary hyperparathyroidism commonly develops.

  • Bone health concerns: Levels in the 16-32 ng/mL range are associated with reduced bone mineral density and increased hip fracture rates, particularly in individuals over age 60 2.

  • Calcium absorption: When postmenopausal women increased their 25(OH)D from 20 ng/mL to 32 ng/mL, intestinal calcium absorption efficiency improved by 45-65% 1.

Context-Specific Considerations

The clinical significance varies by patient population:

In CKD patients (Stages 3-4): The K/DOQI guidelines 2 explicitly state that levels below 30 ng/mL indicate vitamin D insufficiency requiring supplementation with ergocalciferol. This is particularly important as 76% of CKD patients with GFR 20-50 mL/min/1.73 m² have levels below 26 ng/mL 2.

In high-risk populations: Levels >30 ng/mL are specifically recommended for patients aged >65 years, those with recurrent falls, fragility fractures, osteoporosis, secondary hyperparathyroidism, chronic kidney disease, or cancer 3.

In general healthy adults: The 2016 Global Rickets Consensus 4 uses a more conservative threshold, defining insufficiency as 30-50 nmol/L (12-20 ng/mL) and sufficiency as ≥50 nmol/L (≥20 ng/mL).

Important Caveats

Recent guideline evolution: The 2024 Endocrine Society Guideline Communication 5 represents a significant shift, stating they no longer endorse the 30 ng/mL sufficiency threshold due to lack of RCT evidence supporting specific 25(OH)D thresholds for supplementation benefit. However, this applies primarily to supplementation decisions in healthy individuals, not to the diagnostic classification of vitamin D status itself.

Assay variability: All 25(OH)D measurements are subject to methodological variability 1. Targeting values above current cut points (e.g., 40 ng/mL) ensures the true value exceeds 30 ng/mL despite assay variation.

Population-specific considerations: African Americans paradoxically have lower fracture rates despite lower 25(OH)D levels 6, suggesting that universal thresholds may not apply equally across all populations.

Practical Interpretation

For clinical purposes, 26 ng/mL represents vitamin D insufficiency that typically warrants treatment, particularly in patients with:

  • Age >60 years
  • Bone health concerns
  • Chronic kidney disease
  • Malabsorption conditions
  • Limited sun exposure
  • Dark skin pigmentation at higher latitudes

The diagnosis should prompt evaluation for secondary hyperparathyroidism (elevated PTH), assessment of calcium and phosphorus levels, and consideration of vitamin D supplementation to achieve levels ≥30 ng/mL 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.